Quantitative Analysis of Pharmaceutical Polymorphic Forms via the DD Method

    Application Note B-XRD1120


    Organic compounds represented by drug substances sometimes have crystal structures with a low symmetry in molecular arrangement, and dozens of peaks are observed in the X-ray diffraction profile. With a mixture of compounds exhibiting such a complex profile, peak separation is difficult. For this reason, it was also difficult to obtain an accurate value in quantitative analysis that calculates the weight fraction from the integrated intensity of the separated peak. The new quantitative analysis method developed by Rigaku; Direct Derivation method (DD method) calculates the quantitative value based on the single-phase diffraction profile (1) (2). This improves the peak separation accuracy of mixtures that shows complex profiles and makes quantification straightforward. In this application, quantitative analysis of trace amounts of pharmaceutical polymorphic forms was conducted as an example.

    Measurements and results 

    Carbamazepine (CBZ) has crystal polymorphisms of form I (space group: P21/n) and form III (space group: P1). Figure 1 shows the multiple writing of form I and III diffraction profiles. It can be seen that there is a lot of peak overlaps between form I and form III. 1.00 mass% of form III was mixed with form I, and X-ray diffraction for 2θ = 3 to 120° was measured at 10° / min (1 measurement approx. 12 minutes). Figure 2 shows the result of the refinement of the calculated profiles for the obtained profile. Although the Rwp value is high due to the effect of the preferred orientation of the crystals, the quantitative value of 0.99 ± 0.09 mass% for form III was obtained for the preparation value of 1.00 mass%. 

    B-XRD1120 Figure 1 Multiple X-ray diffraction profiles of CBZ form I and form III

    Figure 1: Multiple X-ray diffraction profiles of CBZ form I and form III 

    B-XRD1120 Figure 2  Refinement result of CBZ mixture
    Figure 2: Refinement result of CBZ mixture (99.00% form I and 1.00% of form III were mixed) 


    (1) H. Toraya: J. Appl. Cryst., 49 (2016) 1508-1516. 
    (2) H. Toraya: J. Appl. Cryst., 50 (2017) 820–829.

    Contact Us

    Whether you're interested in getting a quote, want a demo, need technical support, or simply have a question, we're here to help.